ProPhase Labs, Inc. - COM (PRPH)

Q1 2015 13F Holders as of 31 Mar 2015

Type / Class
Equity / COM
Total 13F shares
1,798,257
Share change
-14,231
Total reported value
$2,354,000
Price per share
$1.31
Number of holders
14
Value change
-$18,315
Number of buys
4
Number of sells
3

Institutional Holders of ProPhase Labs, Inc. - COM (PRPH) as of Q1 2015

As of 31 Mar 2015, ProPhase Labs, Inc. - COM (PRPH) was held by 14 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,798,257 shares. The largest 10 holders included MORGAN STANLEY, Vantage Investment Partners, LLC, Bank of New York Mellon Corp, DIMENSIONAL FUND ADVISORS LP, VANGUARD GROUP INC, PNC Financial Services Group, Inc., RENAISSANCE TECHNOLOGIES LLC, Commonwealth Equity Services, Inc, Citadel Advisors LLC, and UBS Group AG. This page lists 14 institutional shareholders reporting positions in this security for the Q1 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.